110 related articles for article (PubMed ID: 12631469)
1. DOPA cyclohexyl ester potently inhibits aglycemia-induced release of glutamate in rat striatal slices.
Hashimoto M; Miyamae T; Yamamoto I; Goshima Y
Neurosci Res; 2003 Mar; 45(3):335-44. PubMed ID: 12631469
[TBL] [Abstract][Full Text] [Related]
2. Endogenously released DOPA is a causal factor for glutamate release and resultant delayed neuronal cell death by transient ischemia in rat striata.
Furukawa N; Arai N; Goshima Y; Miyamae T; Ohshima E; Suzuki F; Fujita K; Misu Y
J Neurochem; 2001 Feb; 76(3):815-24. PubMed ID: 11158253
[TBL] [Abstract][Full Text] [Related]
3. [Is endogenously released DOPA itself an upstream factor for increase in glutamate release and delayed neuronal cell death induced by transient ischemia in rats?].
Misu Y; Furukawa N; Arai N; Miyamae T; Goshima Y
Nihon Yakurigaku Zasshi; 1998 Oct; 112 Suppl 1():93P-97P. PubMed ID: 10190142
[TBL] [Abstract][Full Text] [Related]
4. L-dopa induces Ca(2+)-dependent and tetrodotoxin-sensitive release of endogenous glutamate from rat striatal slices.
Goshima Y; Ohno K; Nakamura S; Miyamae T; Misu Y; Akaike A
Brain Res; 1993 Jul; 617(1):167-70. PubMed ID: 8104083
[TBL] [Abstract][Full Text] [Related]
5. DOPA cyclohexyl ester, a competitive DOPA antagonist, protects glutamate release and resultant delayed neuron death by transient ischemia in hippocampus CA1 of conscious rats.
Arai N; Furukawa N; Miyamae T; Goshima Y; Sasaki Y; Ohshima E; Suzuki F; Fujita K; Misu Y
Neurosci Lett; 2001 Feb; 299(3):213-6. PubMed ID: 11165773
[TBL] [Abstract][Full Text] [Related]
6. [A DOPA antagonist, DOPA cyclohexyl ester inhibits transient brain ischemia-induced release of glutamate and delayed neuronal cell death in striatal and hippocampal region of in vivo rats].
Goshima Y; Furukawa N; Arai N; Miyamae T; Sasaki Y; Hashimoto M; Yamamoto I; Fujita K; Akaike A; Misu Y
Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():180P-185P. PubMed ID: 10629877
[TBL] [Abstract][Full Text] [Related]
7. L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices.
Goshima Y; Nakamura S; Misu Y
J Pharmacol Exp Ther; 1991 Aug; 258(2):466-71. PubMed ID: 1865350
[TBL] [Abstract][Full Text] [Related]
8. Biphasic actions of L-DOPA on the release of endogenous dopamine via presynaptic receptors in rat striatal slices.
Misu Y; Goshima Y; Kubo T
Neurosci Lett; 1986 Dec; 72(2):194-8. PubMed ID: 3808473
[TBL] [Abstract][Full Text] [Related]
9. Nicotine releases stereoselectively and Ca2(+)-dependently endogenous 3,4-dihydroxyphenylalanine from rat striatal slices.
Misu Y; Goshima Y; Nakamura S; Kubo T
Brain Res; 1990 Jun; 520(1-2):334-7. PubMed ID: 2119849
[TBL] [Abstract][Full Text] [Related]
10. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
Jackson D; Abercrombie ED; Zigmond MJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
[TBL] [Abstract][Full Text] [Related]
11. In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
Matsushita N; Misu Y; Goshima Y
Eur J Pharmacol; 2009 Mar; 605(1-3):109-13. PubMed ID: 19168057
[TBL] [Abstract][Full Text] [Related]
12. Transmitter-like release of endogenous 3,4-dihydroxyphenylalanine from rat striatal slices.
Goshima Y; Kubo T; Misu Y
J Neurochem; 1988 Jun; 50(6):1725-30. PubMed ID: 2897424
[TBL] [Abstract][Full Text] [Related]
13. L-DOPA cyclohexyl ester is a novel potent and relatively stable competitive antagonist against L-DOPA among several L-DOPA ester compounds.
Furukawa N; Goshima Y; Miyamae T; Sugiyama Y; Shimizu M; Ohshima E; Suzuki F; Arai N; Fujita K; Misu Y
Jpn J Pharmacol; 2000 Jan; 82(1):40-7. PubMed ID: 10874587
[TBL] [Abstract][Full Text] [Related]
14. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
GoĊembiowska K; Dziubina A
Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
[TBL] [Abstract][Full Text] [Related]
15. [Studies on novel, stable and potent competitive antagonists against L-DOPA].
Misu Y; Goshima Y; Miyamae T; Furukawa N; Okumura Y; Sugiyama Y; Shimizu M
Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():159P-164P. PubMed ID: 9503425
[TBL] [Abstract][Full Text] [Related]
16. L-dopa facilitates the release of endogenous norepinephrine and dopamine via presynaptic beta 1- and beta 2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices.
Goshima Y; Nakamura S; Misu Y
Jpn J Pharmacol; 1990 May; 53(1):47-56. PubMed ID: 1972204
[TBL] [Abstract][Full Text] [Related]
17. Is pharmacological neuroprotection dependent on reduced glutamate release?
Calabresi P; Picconi B; Saulle E; Centonze D; Hainsworth AH; Bernardi G
Stroke; 2000 Mar; 31(3):766-72; discussion 773. PubMed ID: 10700517
[TBL] [Abstract][Full Text] [Related]
18. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
Treseder SA; Rose S; Jenner P
Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: a dual-label microdialysis study.
Patel DR; Young AM; Croucher MJ
Neuroscience; 2001; 102(1):101-11. PubMed ID: 11226673
[TBL] [Abstract][Full Text] [Related]
20. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
Biggs CS; Fisher A; Starr MS
Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
